Related references
Note: Only part of the references are listed.Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an observational cohort study
Claudia Weiss et al.
LANCET CHILD & ADOLESCENT HEALTH (2022)
Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy
Nicolas J. Abreu et al.
PEDIATRIC PULMONOLOGY (2021)
Gene Therapy for Duchenne Muscular Dystrophy
Nertiyan Elangkovan et al.
Journal of Neuromuscular Diseases (2021)
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
Eugenio Mercuri et al.
LANCET NEUROLOGY (2021)
Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy
Deepa Chand et al.
JOURNAL OF HEPATOLOGY (2021)
Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
Deepa H. Chand et al.
JOURNAL OF PEDIATRICS (2021)
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W. Day et al.
LANCET NEUROLOGY (2021)
Gene therapy for ALS: A review
Defne A. Amado et al.
MOLECULAR THERAPY (2021)
Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit
Meaghan Van Alstyne et al.
NATURE NEUROSCIENCE (2021)
Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy
Jerry R. Mendell et al.
JAMA NEUROLOGY (2021)
Viral vector platforms within the gene therapy landscape
Jote T. Bulcha et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy
Debra Stevens et al.
ANNALS OF PHARMACOTHERAPY (2020)
European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy
Janbernd Kirschner et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2020)
Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy
James M. Wilson et al.
HUMAN GENE THERAPY (2020)
Combination molecular therapies for type 1 spinal muscular atrophy
Yohei Harada et al.
MUSCLE & NERVE (2020)
SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS
Christian Mueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Gene Therapy for Spinal Muscular Atrophy: Safety and Early Outcomes
Megan A. Waldrop et al.
PEDIATRICS (2020)
Advancements in AAV-mediated Gene Therapy for Pompe Disease
S. M. Salabarria et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2020)
Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid α-Glucosidase RescuesBoth Muscle and CNS Defects in Murine Pompe Disease
Jeong-A Lim et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Onasemnogene Abeparvovec: First Global Approval
Sheridan M. Hoy
DRUGS (2019)
From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1
Samiah A. Al-Zaidy et al.
PEDIATRIC NEUROLOGY (2019)
AVXS-101 (Onasemnogene Abeparvovec) for SMA 1: Comparative Study with a Prospective Natural History Cohort
Samiah A. Al-Zaidy et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2019)
Therapeutic advances in 5q-linked spinal muscular atrophy
Umbertina Conti Reed et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2018)
Pompe Disease: From Basic Science to Therapy
Lara Kohler et al.
NEUROTHERAPEUTICS (2018)
Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques
Florie Borel et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs
David L. Mack et al.
MOLECULAR THERAPY (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
Caroline Le Guiner et al.
NATURE COMMUNICATIONS (2017)
A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular Dystrophy
Chady H. Hakim et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Viral vectors for gene therapy: Current state and clinical perspectives
A. N. Lukashev et al.
BIOCHEMISTRY-MOSCOW (2016)
Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates
Florie Borel et al.
HUMAN GENE THERAPY (2016)
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
Monica Nizzardo et al.
SCIENCE ADVANCES (2015)
Adenovirus: The First Effective In Vivo Gene Delivery Vector
Ronald G. Crystal
HUMAN GENE THERAPY (2014)
Observational study of spinal muscular atrophy type I and implications for clinical trials
Richard S. Finkel et al.
NEUROLOGY (2014)
Spinal muscular atrophy: going beyond the motor neuron
Gillian Hamilton et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
Elisa Dominguez et al.
HUMAN MOLECULAR GENETICS (2011)
SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments
Peter I. Joyce et al.
MAMMALIAN GENOME (2011)
Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
Marco A. Passini et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Production, Purification and Characterization of Adeno-Associated Vectors
Eduard Ayuso et al.
CURRENT GENE THERAPY (2010)
Viral vectors: from virology to transgene expression
D. Bouard et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
AK Zaiss et al.
JOURNAL OF VIROLOGY (2002)